Literature DB >> 2566608

Dopamine-1-mediated stimulation of phospholipase C activity in rat renal cortical membranes.

C C Felder1, M Blecher, P A Jose.   

Abstract

Phospholipase C (PL-C) mediates transduction of neurotransmitter signals across membranes via hydrolysis of phosphatidylinositol-4,5-bisphosphate (PIP2), leading to generation of second messengers inositol-1,4,5-trisphosphate and diacylglycerol. In this study, dopamine-1 (DA-1) but not dopamine-2 (DA-2) agonists were shown to stimulate PL-C activity in renal cortical membranes. The DA-1 agonist, SKF 82526, stimulated the release of inositol phosphates from renal cortical membranes prelabeled with [3H]myoinositol. The majority of the label (75%) was found in phosphatidylinositol followed by PIP2 (15%) and phosphatidylinositol-4-phosphate (10%). A DA-1 specific effect on PL-C activity was also observed in an in vitro assay of PL-C activity in renal cortical membranes and basolateral and brush border membranes using [3H]PIP2 as the substrate. Dopamine and SKF 82526 stimulated the release of inositol phosphates from added [3H]PIP2 in a concentration-dependent manner. This release was blocked by the DA-1 antagonist SCH 23390 but not by the alpha-adrenergic antagonists phentolamine and prazosin. In contrast, the DA-2 agonist LY 171555 had no effect on inositol phosphate release. Guanosine 5'-(3-O-thio)triphosphate enhanced while guanyl-5'-yl thiophosphate attenuated the DA-1 agonist-stimulated PL-C activity. PL-C activity as measured by [3H]PIP2 hydrolysis had a pH optimum of 6.5, was inhibited by Mg2+ concentrations above 1 mM, was linear with time and protein concentration, and was sensitive to phosphatidylserine and calcium concentrations. We conclude that PL-C is activated by DA-1 but not DA-2 agonists in renal cortical membranes as well as both the basolateral and brush border renal tubular membranes. It is speculated that this action may mediate the natriuretic effects of dopamine in renal tubular epithelia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566608

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

2.  Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor.

Authors:  M Glass; C C Felder
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

3.  Dopamine induces neurite retraction in retinal horizontal cells via diacylglycerol and protein kinase C.

Authors:  P dos S Rodrigues; J E Dowling
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Role of calcium in regulation of phosphoinositide signaling pathway.

Authors:  J Patel; R A Keith; A I Salama; W C Moore
Journal:  J Mol Neurosci       Date:  1991       Impact factor: 3.444

5.  Localization of dopamine-1 receptors along the microdissected rat nephron.

Authors:  F Takemoto; T Satoh; H T Cohen; A I Katz
Journal:  Pflugers Arch       Date:  1991-10       Impact factor: 3.657

6.  SKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase C.

Authors:  Sang-Min Lee; Andrew Kant; Daniel Blake; Vishakantha Murthy; Kevin Boyd; Steven J Wyrick; Richard B Mailman
Journal:  Neuropharmacology       Date:  2014-06-12       Impact factor: 5.250

7.  Mechanisms of dopamine effects on Na-K-ATPase activity in Madin-Darby canine kidney (MDCK) epithelial cells.

Authors:  M Shahedi; K Laborde; S Azimi; S Hamdani; C Sachs
Journal:  Pflugers Arch       Date:  1995-04       Impact factor: 3.657

8.  D1-like receptors inhibit insulin-induced vascular smooth muscle cell proliferation via down-regulation of insulin receptor expression.

Authors:  Chunyu Zeng; Yu Han; Hefei Huang; Changqing Yu; Hongmei Ren; Weibin Shi; Duofen He; Lan Huang; Chengming Yang; Xukai Wang; Lin Zhou; Pedro A Jose
Journal:  J Hypertens       Date:  2009-05       Impact factor: 4.844

9.  Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone.

Authors:  C L Smith; O M Conneely; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

10.  Inhibition of proximal convoluted tubule transport by dopamine.

Authors:  M Baum; R Quigley
Journal:  Kidney Int       Date:  1998-11       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.